These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 23751367)
1. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. Hoenen T; Groseth A; Callison J; Takada A; Feldmann H Antiviral Res; 2013 Sep; 99(3):207-13. PubMed ID: 23751367 [TBL] [Abstract][Full Text] [Related]
2. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system. Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038 [TBL] [Abstract][Full Text] [Related]
3. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Uebelhoer LS; Albariño CG; McMullan LK; Chakrabarti AK; Vincent JP; Nichol ST; Towner JS Antiviral Res; 2014 Jun; 106():86-94. PubMed ID: 24713118 [TBL] [Abstract][Full Text] [Related]
4. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions. Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection. Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707 [TBL] [Abstract][Full Text] [Related]
7. Luciferase-Expressing Ebolaviruses as Tools for Screening of Antivirals. Hoenen T Methods Mol Biol; 2017; 1628():189-194. PubMed ID: 28573620 [TBL] [Abstract][Full Text] [Related]
8. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
10. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening. Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685 [TBL] [Abstract][Full Text] [Related]
11. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein. Albariño CG; Wiggleton Guerrero L; Lo MK; Nichol ST; Towner JS Virology; 2015 Oct; 484():259-264. PubMed ID: 26122472 [TBL] [Abstract][Full Text] [Related]